Universidad San Sebastián  
 

Repositorio Institucional Universidad San Sebastián

Búsqueda avanzada

Descubre información por...

 

Título

Ver títulos
 

Autor

Ver autores
 

Tipo

Ver tipos
 

Materia

Ver materias

Buscar documentos por...




Mostrar el registro sencillo del ítem

dc.contributor.author Morales Osorio, Marco Antonio
dc.contributor.author Ordoñez-Mora, Leidy Tatiana
dc.contributor.author Guil, Rocío
dc.date.accessioned 2026-02-08T03:31:05Z
dc.date.available 2026-02-08T03:31:05Z
dc.date.issued 2025-06-01
dc.identifier.issn 1574-7891
dc.identifier.uri https://repositorio.uss.cl/handle/uss/20552
dc.description.abstract Pain is an unpleasant sensory and emotional experience that may or may not be associated with tissue damage. It is the second most frequent symptom during cancer treatment, arising from factors such as toxicity, surgery, or radiotherapy. Given its multidimensional nature, pain also involves cognitive mechanisms that require complementary therapeutic strategies. Advances in pain neuroscience have improved the understanding and management of painful conditions. The objective of this study was to determine the effectiveness of a neuroscience education program compared to conventional management in individuals with cancer-related pain. Material and Method An experimental study was conducted through a randomized controlled clinical trial with parallel groups and evaluator blinding, in accordance with CONSORT guidelines and registered in ClinicalTrials.gov (Identifier: NCT05581784). An educational protocol based on pain neuroscience principles was developed, consisting of nine sessions addressing topics such as the pain system, alarm mechanisms, modulators, fatigue, anxiety, stress, current treatment models, and goal setting (Ordoñez-Mora et al., 2024). Patients from both the control and intervention groups were evaluated after 10 weeks (Ordoñez-Mora et al., 2023). Results and Discussion A total of 66 patients with cancer pain were included, with breast cancer being the most prevalent diagnosis. In terms of cancer staging, 63% were in stage III, 31.8% in stage IV, and 4.5% in stage V. Pain intensity was assessed using the Visual Analogue Scale (VAS). In the intervention group, the mean pain score decreased from 5.41 ± 2.13 at baseline (T1) to 4.00 ± 2.06 at follow-up (T2), representing a reduction of 1.40 points (p = 0.00), which was both statistically significant and clinically relevant. In contrast, the control group showed no significant change, with mean scores of 5.47 ± 2.30 at T1 and 5.39 ± 2.15 at T2 (difference: 0.078; p = 0.79). Conclusion This study demonstrated that an intervention based on pain neuroscience education produced significant and clinically meaningful reductions in pain intensity in individuals with cancer pain. es
dc.language.iso eng
dc.relation.ispartof vol. 19 Issue: no. 1 Pages: 661
dc.source Molecular Oncology
dc.title Results of a Neuroscience Education Program in Adults with Cancer Pain: A Controlled Clinical Trial en
dc.title.alternative Resultados de un programa de educación en neurociencia en adultos con dolor oncológico: un ensayo clínico controlado es
dc.type Artículo de conferencia
dc.identifier.doi 10.1002/1878-0261.70070
dc.publisher.department Facultad de Ciencias de la Rehabilitación y Calidad de Vida

 

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem